America Great Health (AAGH) — SEC Financial Statements & Analysis

America Great Health (AAGH) is a pharmaceutical preparations company, incorporated in CA. America Great Health trades on OTC as: AAGH. America Great Health (AAGH)'s most recent SEC filing is a Form 10-Q for the period ended 2026-03-31, filed with the SEC on 2026-08-06. Based on that filing, America Great Health carries a market cap of $2.12M, a P/E ratio of -3.16x, a P/B ratio of -0.43x, a P/S ratio of 5.82x, an enterprise value of $5.20M, and an EV/EBITDA multiple of -14.05x. On profitability, it posts a gross margin of 68.58%, an operating margin of -105.19%, a net margin of -184.13%, a Return on Equity (ROE) of 12.86%, and a Return on Assets (ROA) of -308.23%. Per share, it reports EPS of $-0.00, diluted EPS of $-0.00, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -5.10% year-over-year, net income growth of -41.64% year-over-year, and EPS growth of -41.64% year-over-year. On the balance sheet, it maintains a current ratio of 0.06x, a quick ratio of 0.01x, working capital of $-2.48M, a debt-to-equity ratio of -1.03x, a debt ratio of 30.21, an interest coverage ratio of -1.05x, free cash flow of $-352.84K (TTM), and net debt of $3.09M. Figures sourced from SEC EDGAR.

Market Cap

$2.12M

P/E TTM

-3.16x

EPS TTM

$-0.00

P/B TTM

-0.43x

ROE TTM

12.86%

ROA TTM

-308.23%

Debt To Equity

-1.03x

Free Cash Flow TTM

$-352.84K

Net Revenue TTM Growth 1Y

-5.10%

Data as of 2026-03-31 · Source: SEC EDGAR